Namita Thapar is a leading entrepreneur in the country. She has accomplished incredible feats in her business journey. As the Executive Director of Emcure Pharmaceuticals, Namita Thapar has contributed significantly to the global success of the company. Let’s delve deeper into her journey of becoming a businesswoman. 

Emcure Pharmaceuticals is counted among the leading pharmaceutical companies in India. Additionally, Namita Thapar is recognized as an investor on the TV reality show Shark Tank India. She has served as an investor in the show for three seasons. 

Background

Namita Thapar was born on 21 March 1977 into a traditional Gujarati family in Pune, Maharashtra. Since childhood, she was bright in academics. At the young age of 21, she achieved a significant milestone by completing her Chartered Accountancy (CA) from the Institute of Chartered Accountants of India (ICAI). Then, she pursued an MBA degree at Duke University’s Fuqua School of Business.

Professional career

Namita Thapar began her professional career at a company situated in the Bay Area of the United States. She worked in marketing and finance departments for six years. Upon returning to India, Namita assumed the role of Chief Financial Officer (CFO) at her father’s company Emcure Pharmaceuticals. After serving as a CFO for a decade, she embarked on new business adventures. 

Incredible Ventures Limited

Namita Thapar founded the company Incredible Ventures Limited. It is an organization dedicated to offering entrepreneurship training to the youth of India. She is also the CEO of the company. Moreover, Namita holds membership in the Young Presidents Organization Pune Chapter. As a young businesswoman, Namita was dedicated to acquiring new skills. Today, her net worth is estimated to be around Rs 600 crore. 

Namita Thapar’s family

Namita Thapar regards her mother as her role model as she always encouraged her to become a successful businesswoman. Namita and her husband, Vikas Thapar, are proud parents of two sons named Jai Thapar and Veer Thapar.